Mar 14
|
Pharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
Mar 14
|
3 European Penny Stocks With Market Caps Over €300M
|
Mar 14
|
Pharming Group Full Year 2024 Earnings: EPS Beats Expectations
|
Mar 13
|
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
|
Feb 20
|
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
|
Oct 10
|
Pharming Group to report third quarter 2024 financial results on October 24
|
Aug 9
|
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
|